Adzenys XR-ODT
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $142,943 | 7,056 | 3,316 |
| 2023 | $183,447 | 7,518 | 2,886 |
| 2022 | $162,953 | 8,478 | 2,896 |
| 2021 | $129,676 | 6,730 | 2,494 |
| 2020 | $100,918 | 6,846 | 2,749 |
| 2019 | $266,303 | 13,206 | 4,513 |
| 2018 | $1.5M | 16,484 | 6,160 |
| 2017 | $1.4M | 22,860 | 8,163 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.8M | 905 | 45.2% |
| Food and Beverage | $1.6M | 86,872 | 41.0% |
| Travel and Lodging | $285,393 | 972 | 7.2% |
| Unspecified | $202,439 | 355 | 5.1% |
| Consulting Fee | $55,875 | 74 | 1.4% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| An Open-Label, Single-Dose Pharmacokinetic Study of ADZENYS XR ODT in Male and Female Children 4 to Less Than 6 Years of Age With Attention-Deficit/Hyperactivity Disorder (ADHD) | Neos Therapeutics, LP | $202,439 | 12 |
Top Doctors Receiving Payments for Adzenys XR-ODT
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Adolescent Medicine | Midlothian, VA | $216,233 | 444 |
| , M.D | Psychiatry | Northbrook, IL | $212,752 | 316 |
| Unknown | — | Tampa, FL | $188,680 | 279 |
| , MD | Psychiatry | Hallandale Beach, FL | $99,012 | 160 |
| , MD | Pediatrics | High Point, NC | $89,635 | 222 |
| , M.D | Child & Adolescent Psychiatry | Houston, TX | $63,714 | 88 |
| , MD | Psychiatry | Baltimore, MD | $60,289 | 199 |
| , M.D | Psychiatry | Kansas City, MO | $57,384 | 73 |
| , MD | Neurodevelopmental Disabilities | Winter Park, FL | $56,698 | 75 |
| , MD | Child & Adolescent Psychiatry | Houston, TX | $50,838 | 119 |
| , M.D | Prescribing (Medical) | Greenwood Village, CO | $50,382 | 31 |
| , M.D | Developmental - Behavioral Pediatrics | Phoenix, AZ | $50,273 | 82 |
| , M.D | Child & Adolescent Psychiatry | Troy, MI | $49,807 | 63 |
| Derek Ott | — | Los Angeles, CA | $45,954 | 89 |
| , MD | Child & Adolescent Psychiatry | Framingham, MA | $43,082 | 92 |
| , M.D | Psychiatry | Nashville, TN | $42,218 | 58 |
| , M.D | Psychiatry | Austin, TX | $37,892 | 130 |
| , M.D | Psychiatry | Weldon Spring, MO | $34,689 | 74 |
| , MD | Psychiatry | Andover, MA | $34,126 | 87 |
| , MD | Child & Adolescent Psychiatry | Lexington, SC | $33,970 | 51 |
| , MD | Psychosomatic Medicine | Fishers, IN | $31,678 | 46 |
| , MD | Pediatrics | Orland Park, IL | $31,306 | 59 |
| Ann Childress | Child & Adolescent Psychiatry | Las Vegas, NV | $31,048 | 48 |
| , DO | Psychiatry | Brooklyn, NY | $30,099 | 40 |
| , M.D | Child & Adolescent Psychiatry | Gulfport, FL | $28,726 | 47 |
Manufacturing Companies
- Neos Therapeutics, LP $3.9M
- Aytu BioPharma, Inc. $7,339
- AYTU BioPharma, Inc. $673.88
Product Information
- Type Drug
- Total Payments $3.9M
- Total Doctors 17,946
- Transactions 89,178
About Adzenys XR-ODT
Adzenys XR-ODT is a drug associated with $3.9M in payments to 17,946 healthcare providers, recorded across 89,178 transactions in the CMS Open Payments database. The primary manufacturer is Neos Therapeutics, LP.
Payment data is available from 2017 to 2024. In 2024, $142,943 was paid across 7,056 transactions to 3,316 doctors.
The most common payment nature for Adzenys XR-ODT is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.8M, 45.2% of total).
Adzenys XR-ODT is associated with 1 research study, including "An Open-Label, Single-Dose Pharmacokinetic Study of ADZENYS XR ODT in Male and Female Children 4 to Less Than 6 Years of Age With Attention-Deficit/Hyperactivity Disorder (ADHD)" ($202,439).